| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
38,634 |
35,201 |
$3.03M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
36,164 |
35,429 |
$2.98M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
18,083 |
17,810 |
$2.09M |
| 90832 |
Psychotherapy, 30 minutes with patient |
10,548 |
5,076 |
$1.64M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
17,230 |
15,682 |
$1.18M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
12,126 |
11,897 |
$801K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
10,500 |
10,492 |
$707K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
9,822 |
8,648 |
$576K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,321 |
1,279 |
$399K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
9,898 |
5,890 |
$373K |
| 99460 |
|
3,354 |
3,333 |
$319K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,049 |
2,900 |
$317K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
4,306 |
3,497 |
$315K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
6,528 |
5,507 |
$314K |
| 99221 |
|
3,660 |
3,502 |
$279K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,320 |
4,320 |
$250K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,835 |
1,791 |
$233K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
2,822 |
2,800 |
$219K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,217 |
1,200 |
$191K |
| 36415 |
Collection of venous blood by venipuncture |
5,117 |
4,386 |
$178K |
| 88307 |
|
1,657 |
1,578 |
$165K |
| 80053 |
Comprehensive metabolic panel |
3,749 |
3,284 |
$153K |
| 70450 |
Computed tomography, head or brain; without contrast material |
411 |
404 |
$120K |
| 97803 |
|
1,809 |
1,742 |
$110K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,741 |
1,741 |
$104K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,314 |
2,187 |
$101K |
| 99381 |
|
1,608 |
1,608 |
$92K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
732 |
573 |
$69K |
| 86850 |
|
1,139 |
1,049 |
$65K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,473 |
944 |
$63K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
851 |
181 |
$57K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
711 |
708 |
$55K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
382 |
375 |
$47K |
| 99462 |
|
1,101 |
1,012 |
$45K |
| 97802 |
|
360 |
357 |
$40K |
| 81025 |
|
2,406 |
2,278 |
$37K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
600 |
598 |
$33K |
| 99233 |
Prolong inpt eval add15 m |
320 |
308 |
$32K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
653 |
604 |
$28K |
| 88304 |
|
1,722 |
1,676 |
$26K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
982 |
835 |
$25K |
| 86901 |
|
1,147 |
1,055 |
$24K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
126 |
125 |
$21K |
| 90677 |
|
228 |
228 |
$19K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
325 |
320 |
$19K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
56 |
56 |
$19K |
| 86900 |
|
1,140 |
1,052 |
$18K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
116 |
110 |
$14K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
87 |
80 |
$11K |
| 90686 |
|
552 |
552 |
$11K |
| 90791 |
Psychiatric diagnostic evaluation |
51 |
48 |
$10K |
| 76820 |
|
843 |
460 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
206 |
205 |
$8K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
641 |
574 |
$8K |
| 71046 |
Radiologic examination, chest; 2 views |
792 |
785 |
$7K |
| 85610 |
|
2,056 |
1,942 |
$7K |
| J2704 |
Injection, propofol, 10 mg |
2,087 |
1,433 |
$7K |
| 80050 |
General health panel |
193 |
189 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,878 |
4,182 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
303 |
298 |
$6K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,721 |
1,588 |
$5K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,703 |
1,584 |
$5K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
142 |
142 |
$5K |
| H2010 |
Comprehensive medication services, per 15 minutes |
337 |
311 |
$5K |
| 99442 |
|
149 |
144 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,800 |
1,693 |
$4K |
| 90670 |
|
203 |
203 |
$4K |
| 80061 |
Lipid panel |
272 |
269 |
$4K |
| 85730 |
|
1,895 |
1,796 |
$4K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
135 |
133 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
183 |
182 |
$2K |
| 90656 |
|
91 |
91 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
112 |
111 |
$2K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
716 |
704 |
$2K |
| 83655 |
|
169 |
168 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,605 |
1,543 |
$2K |
| 90715 |
|
53 |
53 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,406 |
1,402 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
787 |
758 |
$2K |
| 80076 |
|
107 |
105 |
$1K |
| 0001A |
|
29 |
29 |
$1K |
| 90697 |
|
52 |
52 |
$1K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
257 |
256 |
$1K |
| 90681 |
|
46 |
46 |
$1K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
550 |
453 |
$1K |
| 99441 |
|
48 |
45 |
$1K |
| 0002A |
|
22 |
22 |
$1K |
| 98967 |
|
68 |
66 |
$910.05 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
193 |
189 |
$833.56 |
| 90648 |
|
46 |
46 |
$821.10 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
703 |
693 |
$792.61 |
| 99222 |
Initial hospital care, per day, moderate complexity |
15 |
15 |
$767.72 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
954 |
932 |
$755.55 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
188 |
170 |
$751.44 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,811 |
1,750 |
$723.65 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
26 |
13 |
$715.47 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
16 |
16 |
$649.61 |
| 98968 |
|
22 |
22 |
$592.23 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
389 |
367 |
$559.87 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
548 |
529 |
$556.71 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,230 |
1,223 |
$517.82 |
| 90723 |
|
26 |
26 |
$464.10 |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
13 |
13 |
$459.89 |
| 92002 |
|
15 |
15 |
$444.18 |
| 99051 |
|
35 |
27 |
$414.30 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
73 |
73 |
$386.63 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
182 |
181 |
$365.23 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
26 |
26 |
$356.00 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
14 |
14 |
$336.93 |
| 88302 |
|
48 |
39 |
$336.42 |
| 90698 |
|
12 |
12 |
$301.20 |
| 81001 |
|
1,884 |
1,820 |
$284.01 |
| 99402 |
|
13 |
13 |
$272.00 |
| 87088 |
|
1,119 |
1,083 |
$234.29 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
457 |
342 |
$218.59 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
905 |
787 |
$141.04 |
| 84443 |
Thyroid stimulating hormone (TSH) |
26 |
24 |
$134.40 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
50 |
42 |
$105.20 |
| 82550 |
|
710 |
668 |
$100.58 |
| 84484 |
|
891 |
781 |
$94.47 |
| 83735 |
|
379 |
255 |
$91.69 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
13 |
13 |
$70.74 |
| 83605 |
|
355 |
321 |
$67.07 |
| Q3014 |
Telehealth originating site facility fee |
13 |
12 |
$63.03 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
87 |
86 |
$57.92 |
| 84702 |
|
29 |
27 |
$45.15 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
26 |
25 |
$43.93 |
| 86140 |
|
158 |
153 |
$42.07 |
| 81003 |
|
199 |
196 |
$40.59 |
| 85027 |
|
336 |
323 |
$37.75 |
| 82947 |
|
562 |
407 |
$34.48 |
| 85007 |
|
319 |
309 |
$33.76 |
| 86592 |
|
52 |
50 |
$21.14 |
| 83690 |
|
1,036 |
1,010 |
$19.29 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
52 |
51 |
$16.53 |
| 82150 |
|
407 |
402 |
$13.94 |
| 87040 |
|
70 |
50 |
$9.76 |
| 87070 |
|
72 |
70 |
$9.57 |
| 84100 |
|
102 |
69 |
$9.48 |
| 86803 |
|
27 |
27 |
$5.28 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
41 |
40 |
$2.18 |
| 1126F |
|
1,326 |
1,242 |
$0.00 |
| 1036F |
|
3,701 |
3,157 |
$0.00 |
| 94761 |
|
1,370 |
1,338 |
$0.00 |
| 80320 |
|
233 |
209 |
$0.00 |
| 1125F |
|
126 |
122 |
$0.00 |
| 94760 |
|
252 |
247 |
$0.00 |
| G8732 |
No documentation of pain assessment, reason not given |
242 |
229 |
$0.00 |
| 88720 |
|
37 |
32 |
$0.00 |
| 82553 |
|
13 |
13 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
12 |
12 |
$0.00 |
| 1159F |
|
2,171 |
1,999 |
$0.00 |
| 1160F |
|
1,731 |
1,595 |
$0.00 |
| 87400 |
|
110 |
110 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
25 |
24 |
$0.00 |